LRMR
#3356
Larimar Therapeutics, Inc. - Common Stock
2.5 3 USD
-0.05%
Market Price
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
Годовой диапазон
Дневное изменение
-5.24%
Месячное изменение
-34.11%
6-месячное изменение
-48.47%
Годовое изменение
-39.33%
Предыдущее закрытие
2.6 7
Open
2.6 6
Low
2.5 3
High
2.6 9
Financials
2023
Annual report, FY2023
Larimar Therapeutics, Inc. annual report, FY2023
10-K
Current report, 14 Nov 2023
Larimar Therapeutics, Inc. current report, 14 November 2023
8-K
Current report, 03 Oct 2023
Larimar Therapeutics, Inc. current report, 03 October 2023
8-K
Quarterly report, Q3 FY2023
Larimar Therapeutics, Inc. quarterly report, Q3 FY2023
10-Q
Current report, 14 Aug 2023
Larimar Therapeutics, Inc. current report, 14 August 2023
8-K
Current report, 10 Aug 2023
Larimar Therapeutics, Inc. current report, 10 August 2023
8-K
Current report, 25 Jul 2023
Larimar Therapeutics, Inc. current report, 25 July 2023
8-K
Current report, 17 Jul 2023
Larimar Therapeutics, Inc. current report, 17 July 2023
8-K
Quarterly report, Q2 FY2023
Larimar Therapeutics, Inc. quarterly report, Q2 FY2023
10-Q
Current report, 01 Jun 2023
Larimar Therapeutics, Inc. current report, 01 June 2023
8-K